Bococizumab Antibody
Bococizumab (PF-04950615) is a humanized monoclonal antibody targeting PCSK9, used to lower LDL cholesterol in hypercholesterolemia. It has been applied in clinical and preclinical research to investigate PCSK9 inhibition, lipid metabolism, and cardiovascular disease models in both in vitro and in vivo studies.
Product Specifications
Product Name Alternative
PCSK9, Bococizumab, RN316, RN-316, RN 316, PF 04950615, PF04950615, PF-04950615
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
2.8 mg/mL
Purity
97.70% (May vary between batches)
Molecular Weight
145.0 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2824286-01 20 µg
Recombinant Human RBFOX3 Protein, N-GST & C-His
Sign In for Pricing
View Details orb2824286-02 50 µg
Recombinant Human RBFOX3 Protein, N-GST & C-His
Sign In for Pricing
View Details orb2824286-03 100 µg
Recombinant Human RBFOX3 Protein, N-GST & C-His
Sign In for Pricing
View Details 
039789-ML405 100 µL
PDCD4, ID (PDCD4, H731, Programmed cell death protein 4, Neoplastic transformation inhibitor protein, Nuclear antigen H731-like, Protein 197/15a) (MaxLight 405) discontinued
Sign In for Pricing
View Details